Re: Neutralizing antibodies to interferon beta-1b are not associated with disease worsening in multiple sclerosis.
Farrell
Rachel
R
Bendtzen
Klaus
K
Bertolotto
Antonio
A
Clark
Berwyn
B
Comabella
Manuel
M
Deisenhammer
Florian
F
Fogdell-Hahn
Anna
A
Giovannoni
Gavin
G
Hartung
Hans Peter
HP
Hemmer
Bernard
B
Hillert
Jan
J
Kappos
Ludwig
L
Killestein
Joep
J
Lindberg
Raija
R
Montalban
Xavier
X
Polman
Chris
C
Sorensen
Per Soelberg
PS
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D019138:Antibodies, Blocking / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D006801:Humans; D000068576:Interferon beta-1b; D016899:Interferon-beta / Q000276:immunology*; D009103:Multiple Sclerosis / Q000188:drug therapy* / Q000276:immunology; D009500:Neutralization Tests; D016896:Treatment Outcome
D000276:Adjuvants, Immunologic; D019138:Antibodies, Blocking; D000068576:Interferon beta-1b; D016899:Interferon-beta